Ablación por radiofrecuencia exitosa de miomas uterinos muy grandes: estudio de 2 casos

IF 0.1 Q4 OBSTETRICS & GYNECOLOGY

Clinica e Investigacion en Ginecologia y Obstetricia Pub Date : 2025-09-02 DOI:10.1016/j.gine.2025.101065

C. Torrijo Rodrigo, V. Gómez García, C. Giménez Molina

{"title":"Ablación por radiofrecuencia exitosa de miomas uterinos muy grandes: estudio de 2 casos","authors":"C. Torrijo Rodrigo, V. Gómez García, C. Giménez Molina","doi":"10.1016/j.gine.2025.101065","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Radiofrequency ablation (RFA) is one of the latest minimally invasive treatment options for symptomatic uterine fibroids. The primary goal is to evaluate the feasibility and effectiveness of RFA as a minimally invasive treatment for large uterine fibroids, preserving the uterus and fertility.</div></div><div><h3>Main symptoms and/or clinical findings</h3><div>Two women, aged 47 and 40, with very large fibroids (approximately 10cm in length) exhibited symptoms such as hypermenorrhea, urinary symptoms, back pain, and a painful mass.</div></div><div><h3>Main diagnoses, therapeutic interventions, and outcomes</h3><div>Uterine leiomyomas or fibroids. RFA was performed using a 35cm monopolar electrode with a 17 gauge and a 10mm active tip. The sizes of the fibroids were reduced by more than half, and symptoms disappeared after the procedure.</div><div>Case 1: A 47-year-old woman with a 10cm fibroid showed a significant reduction in fibroid size (from 437 to 9cm<sup>3</sup>) and complete resolution of symptoms within one year.</div><div>Case 2: A 40-year-old woman with a 10.5cm fibroid experienced a notable reduction in fibroid size (from 472 to 33cm<sup>3</sup>) and resolution of symptoms within six months.</div></div><div><h3>Conclusion</h3><div>These cases demonstrate that RFA is a safe and effective method for treating large uterine fibroids, with significant reductions in fibroid volume and resolution of symptoms. The procedure should be performed by gynecologists experienced in minimally invasive techniques.</div></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"52 4","pages":"Article 101065"},"PeriodicalIF":0.1000,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica e Investigacion en Ginecologia y Obstetricia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0210573X25000358","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction

Radiofrequency ablation (RFA) is one of the latest minimally invasive treatment options for symptomatic uterine fibroids. The primary goal is to evaluate the feasibility and effectiveness of RFA as a minimally invasive treatment for large uterine fibroids, preserving the uterus and fertility.

Main symptoms and/or clinical findings

Two women, aged 47 and 40, with very large fibroids (approximately 10 cm in length) exhibited symptoms such as hypermenorrhea, urinary symptoms, back pain, and a painful mass.

Main diagnoses, therapeutic interventions, and outcomes

Uterine leiomyomas or fibroids. RFA was performed using a 35 cm monopolar electrode with a 17 gauge and a 10 mm active tip. The sizes of the fibroids were reduced by more than half, and symptoms disappeared after the procedure.

Case 1: A 47-year-old woman with a 10 cm fibroid showed a significant reduction in fibroid size (from 437 to 9 cm³) and complete resolution of symptoms within one year.

Case 2: A 40-year-old woman with a 10.5 cm fibroid experienced a notable reduction in fibroid size (from 472 to 33 cm³) and resolution of symptoms within six months.

Conclusion

These cases demonstrate that RFA is a safe and effective method for treating large uterine fibroids, with significant reductions in fibroid volume and resolution of symptoms. The procedure should be performed by gynecologists experienced in minimally invasive techniques.

查看原文本刊更多论文

成功射频切除非常大的子宫肌瘤：2例研究

射频消融（RFA）是治疗症状性子宫肌瘤的最新微创治疗方法之一。主要目的是评估RFA作为一种微创治疗大子宫肌瘤的可行性和有效性，保留子宫和生育能力。主要症状和/或临床表现2例女性，年龄47岁和40岁，患有超大肌瘤（长约10厘米），表现出痛经、尿路症状、背痛和疼痛肿块等症状。子宫平滑肌瘤或肌瘤的主要诊断、治疗措施及结果。RFA使用35 cm单极电极，17 gauge和10 mm有源尖端。肌瘤的大小缩小了一半以上，手术后症状消失。病例1：一名47岁女性，肌瘤为10厘米，肌瘤大小明显减小（从437厘米减小到9厘米），一年内症状完全缓解。病例2：一名患有10.5 cm肌瘤的40岁女性在6个月内肌瘤大小明显减小（从472减小到33 cm3），症状得到缓解。结论RFA是一种安全有效的治疗大肌瘤的方法，肌瘤体积明显缩小，症状明显缓解。手术应由具有微创技术经验的妇科医生进行。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinica e Investigacion en Ginecologia y Obstetricia OBSTETRICS & GYNECOLOGY-

CiteScore

0.20

自引率

0.00%

发文量

期刊介绍： Una excelente publicación para mantenerse al día en los temas de máximo interés de la ginecología de vanguardia. Resulta idónea tanto para el especialista en ginecología, como en obstetricia o en pediatría, y está presente en los más prestigiosos índices de referencia en medicina.